Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Ronald H. Goldstein"'
Iatrogenic esophageal dysmotility as a barrier to transplantation in pulmonary arterial hypertension
Autor:
Michael S. Miller, Shelsey W. Johnson, Alexander R. Opotowsky, Michael J. Landzberg, Nirmal S. Sharma, Hilary J. Goldberg, Alexandra K. Wong, Alison S. Witkin, Josanna Rodriguez-Lopez, Ronald H. Goldstein, Bradley A. Maron, Bradley M. Wertheim
Publikováno v:
JHLT Open, Vol 5, Iss , Pp 100098- (2024)
Esophageal dysmotility is identified as a contraindication to lung transplantation at some centers due to increased risks of acute rejection, pulmonary infection, and chronic lung allograft dysfunction. Phosphodiesterase-type 5 inhibitors (PDE5i) are
Externí odkaz:
https://doaj.org/article/4145d27170eb4e76b982c3e6fb360f36
Autor:
Shelsey W. Johnson, Rui-Sheng Wang, Michael R. Winter, Kari R. Gillmeyer, Katarina Zeder, Elizabeth S. Klings, Ronald H. Goldstein, Renda Soylemez Wiener, Bradley A. Maron
Publikováno v:
ERJ Open Research, Vol 10, Iss 3 (2024)
Background Clinical trials repurposing pulmonary arterial hypertension (PAH) therapies to patients with lung disease- or hypoxia-pulmonary hypertension (PH) (classified as World Health Organization Group 3 PH) have failed to show a consistent benefit
Externí odkaz:
https://doaj.org/article/19d8d7068a8744eb8e1d67da7977ec40
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 3, Pp n/a-n/a (2022)
Abstract Inhaled treprostinil was approved recently for interstitial lung disease‐pulmonary hypertension; however, efficacy in “real‐world” populations is not known. We designed a protocol and report our experience evaluating 10 patients refe
Externí odkaz:
https://doaj.org/article/5707562ec5764b82986cb9cdf09a7e95
Autor:
Bradley A. Maron, Gaurav Choudhary, Rebekah L. Goldstein, Eric Garshick, Matthew Jankowich, Troo J. S. Tucker, Kathleen A. LaCerda, Brack Hattler, Edward C. Dempsey, Ruxana T. Sadikot, Shelley Shapiro, Sharon I. Rounds, Ronald H. Goldstein
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 1, Pp n/a-n/a (2022)
Abstract Treating Veterans with chronic obstructive pulmonary disease complicated by pulmonary hypertension (COPD‐PH) using phosphodiesterase type‐5 inhibitor pharmacotherapy is common, but efficacy data are lacking. To address this further, pati
Externí odkaz:
https://doaj.org/article/9a254e64ecb7404fbc5c4105f6b0c31b
Autor:
Bradley A. Maron, Gaurav Choudhary, Rebekah L. Goldstein, Eric Garshick, Matthew Jankowich, Troo J. S. Tucker, Kathleen A. LaCerda, Brack Hattler, Edward C. Dempsey, Ruxana T. Sadikot, Shelley Shapiro, Sharon I. Rounds, Ronald H. Goldstein
Publikováno v:
Pulmonary circulation. 12(1)
Treating Veterans with chronic obstructive pulmonary disease complicated by pulmonary hypertension (COPD-PH) using phosphodiesterase type-5 inhibitor pharmacotherapy is common, but efficacy data are lacking. To address this further, patients with COP
Publikováno v:
Fed Pract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a10ef07a413291ccbb0d3c09e36be95
https://europepmc.org/articles/PMC7735459/
https://europepmc.org/articles/PMC7735459/
Autor:
George A. Alba, Gabor Kovacs, Ronald H. Goldstein, Tufik R. Assad, Gaurav Choudhary, Horst Olschewski, Ryan J. Tedford, Gérald Simonneau, Bradley A. Maron, Bradley M. Wertheim, Stephen W. Waldo, Marc Humbert, Anna E. Barón, Jane A. Leopold, Evan L. Brittain, Shi Huang, Nazzareno Galiè, Edward Hess
Background: In pulmonary hypertension subgroups, elevated pulmonary vascular resistance (PVR) of 3·0 Wood units or more is associated with poor prognosis. However, the spectrum of PVR risk in pulmonary hypertension is not known. To address this area
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e30d6399439dcb90e8718c17b87c6530
http://hdl.handle.net/11585/863644
http://hdl.handle.net/11585/863644
Autor:
Tim Lahm, Maggie A. Stanislawski, Karen E. Joynt, Mary E. Plomondon, Anna E. Barón, Alexander R. Opotowsky, Jean M. Elwing, John S. Rumsfeld, Gaurav Choudhary, Edward Hess, Daniel J. Kass, Erik R. Swenson, Thomas M. Maddox, Jane A. Leopold, Ryan J. Tedford, Bradley A. Maron, Gary K. Grunwald, Roham T. Zamanian, Ronald H. Goldstein, Thomas Stephens
Background— Pulmonary hypertension (PH) is associated with increased morbidity across the cardiopulmonary disease spectrum. Based primarily on expert consensus opinion, PH is defined by a mean pulmonary artery pressure (mPAP) ≥25 mm Hg. Although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96cf6537fd5c06b17a35580d3682be69
https://europepmc.org/articles/PMC4811678/
https://europepmc.org/articles/PMC4811678/
Autor:
Paul Toselli, Nicholas S. Hill, Jun Yu, Linda Taylor, Daniel S. Green, Philip J. Stone, Peter Polgar, Rod R. Warburton, Celeste B. Rich, Ronald H. Goldstein
Publikováno v:
Journal of Cellular Physiology. 227:2013-2021
The angiotensin II type I receptor (AT1) was modified by replacing its third intracellular loop and C-terminal tail with the corresponding regions from the bradykinin B2 receptor. Transgenic mice were produced that overexpress this mutated receptor (
Autor:
Lingyi Lynn Deng, Ronald H. Goldstein, Wesley W. Brooks, Chester H. Conrad, Steven S. Shen, Oscar H.L. Bing
Publikováno v:
Journal of Molecular and Cellular Cardiology. 49:390-401
To identify biological pathways associated with myocardial recovery from heart failure (HF), gene profiling and gene set enrichment analysis (GSEA) were examined in left ventricle of spontaneously hypertensive rats with HF (SHR-F) with no treatment,